Press ReleasesGetinge releases Livit Flex – the next generation in bioprocess control

Dec 15, 2022 -- Getinge is launching Livit Flex – an intuitive system for bioprocess control that will enable pharmaceuticals and biotech products to reach the market faster.

In bioprocessing, where complete living cells or their components are used to obtain for example pharmaceuticals and cellular agriculture products – flexibility, customization, simplicity as well as time and cost-efficiency are key factors for process optimization.
“Livit Flex brings nearly half a century of expertise together with the latest technologies to deliver an intuitive and easily configurable bioprocess controller that fits any R&D application,” says Matthijs Niemeijer, Head of Product Management Bioreactor Systems at Getinge.

With Livit Flex, Getinge takes bioprocess control to the next level by releasing a state-of-the-art solution that speeds up development thanks to system flexibility, smart sensor technology and easy-to-use software functionalities.

By accessing and controlling multiple controllers from one PC or tablet in a laboratory, users can quickly set up parallel experiments and monitor all that data from one central location.

“Combining the flexibility of the Livit Flex controller, the intuitive Livit software and Getinge bioreactors enables acceleration of R&D processes to make sure that pharmaceuticals and biotech products will ultimately end up faster where they are most needed – with the patients,” says Matthijs.


Human-Centred Design: From Inception to Integration

IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process


The Importance of Temperature Control in Pharmaceutical Analysis

As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research


Providing Support Throughout the Patient Journey

Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?